Moonlake Immunotherapeutics Ag
Clinical trials sponsored by Moonlake Immunotherapeutics Ag, explained in plain language.
-
New drug tested for teen skin condition
Disease control Recruiting nowThis study is testing a drug called sonelokimab in teenagers with a painful, recurring skin condition called hidradenitis suppurativa (HS). It aims to see how the drug behaves in the body and how safe it is for adolescents over 24 weeks of treatment. The study will also check if …
Phase: PHASE3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Apr 02, 2026 03:57 UTC
-
New drug trial offers hope for Tough-to-Treat arthritis
Disease control Recruiting nowThis study is testing whether a new medication called sonelokimab can help control psoriatic arthritis in adults whose current treatments aren't working well enough. It will compare two doses of sonelokimab against a placebo (inactive treatment) and an existing medication in abou…
Phase: PHASE3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC